Suxiao Jiuxin Pills in Microvascular Obstruction in Patients With Acute Coronary Syndrome

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 198 participants.

Also called NCT04814121

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 198 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04814121
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04814121. Randomized; quadruple masking; primary purpose treatment. Start 2021-05-01 (anticipated); primary completion 2023-09-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Suxiao Jiuxin Pills in Microvascular Obstruction in Patients With Acute Coronary Syndrome
Condition
Acute Coronary Syndrome
Intervention (Drug)
Suxiao Jiuxin Pills
Intervention (Drug)
The placebo of Suxiao Jiuxin Pills
Lead sponsor
Guangzhou University of Traditional Chinese Medicine (class: other)

Record details

Record id
cardio:ct-nct04814121
Content hash
5b32a849ed7cc0ddb04542d1676fef79ee8eb8a588dbb5246073167a3c4292f5